Prof.Dr. ALEV GÜRGÜN

Impact of COVID-19 and lockdown on outcomes of COPD patients in Turkey: lessons for the future.

BMC Pulm Med. 2025 Aug 30;25(1):414. doi: 10.1186/s12890-025-03883-8. Varol Y, Baha A, Polatli M, Yaz A, Serifoglu Rahatli I, Kocabas A. Polat Yulug D, Sen E, Alpaydin AO, Nayci S, Ozgur ES, Baydar Toprak O, Sahin AM, Selcuk E, Yigit S, Elmas Uysal F, Gurgun A, Kokturk N, Mammadova A,

Factors Associated with Increasing Costs in Severe Chronic Obstructive Pulmonary Disease Exacerbation: Turkish Thoracic Society Chronic Obstructive Pulmonary Disease Assembly.

Thorac Res Pract. 2024 Jan 3;25(1):17-25. Sertçelik Ü, Yıldız R, İpek Ö, Alpaydın AÖ. Baha A, Köktürk N, Baysan C, Öztürk B, Cengiz SK, Varol Y, Mertoğlu A, Çırak AK, Turan O, Dursunoğlu N, Savurmuş N, Gürgün A, Elmas F, Çöplü L,

Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study).

B.Medicine (Baltimore). 2024 Nov 29;103(48):e40483. Cirak AK, Turan O, Dursunoglu N, Savurmus N, Gurgun A, Elmas F, Çoplu L, Sertcelik U, Yildiz R Baydar Toprak O, Polatli M, Baha A, Kokturk N, Yapar D, Ozkan S, Sen E, Ciftci F, Ozturk B, Kodalak S, Ulubay G, Serifoglu I, Varol Y, Mertoglu A,